These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10171215)

  • 1. Specific list for categorization of laboratory test systems, assays and examinations by complexity--PHS. Notice with comment period.
    Fed Regist; 1992 Aug; 57(168):39211-33. PubMed ID: 10171215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific list for categorization of laboratory test systems, assays and examinations by complexity--PHS. Notice with comment period.
    Fed Regist; 1992 Jul; 57(131):30362-77. PubMed ID: 10171070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific list for categorization of laboratory test systems, assays and examinations by complexity--PHS. Notice with comment period.
    Fed Regist; 1992 Sep; 57(171):40258-96. PubMed ID: 10171216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific list for categorization of laboratory test systems, assays and examinations by complexity--PHS. Notice with comment period.
    Fed Regist; 1992 Feb; 57(40):7245-88. PubMed ID: 10170939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notice of specific list for categorization of laboratory test systems, assays, and examinations by complexity--CDC. Notice with comment period.
    Fed Regist; 1997 Apr; 62(70):17832-49. PubMed ID: 10172993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic composition of the Health Service Delivery Areas (HSDA) established by regulations of the Indian Health Service--PHS. Notice.
    Fed Regist; 1988 Aug; 53(165):32460-6. PubMed ID: 10288494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare, Medicaid, and CLIA programs; clinical laboratory requirements--extension of certain effective dates for clinical laboratory requirements under CLIA--CDC, HCFA. Final rule with comment period.
    Fed Regist; 1997 May; 62(91):25855-8. PubMed ID: 10173015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitation on federal participation for capital expenditures--PHS. Notice of proposed rulemaking.
    Fed Regist; 1983 Aug; 48(155):36390-402. PubMed ID: 10261490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLIA program; categorization of tests and personnel modifications--HCFA. Final rule with comment period.
    Fed Regist; 1995 Apr; 60(78):20035-51. PubMed ID: 10172298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Privacy Act of 1974; annual publication of systems of records--PHS.
    Fed Regist; 1983 Nov; 48(230):53792-5. PubMed ID: 10278207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and Clinical Laboratory Improvement Act Program fee collection--HCFA. Final rule with comment period.
    Fed Regist; 1993 Jan; 58(11):5215-37. PubMed ID: 10171356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; additions to and deletions from the current list of covered surgical procedures for ambulatory surgical centers--HCFA. Final notice with comment period.
    Fed Regist; 1995 Jan; 60(17):5185-204. PubMed ID: 10172208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare, Medicaid, and CLIA programs; extension of certain effective dates for clinical laboratory requirements under CLIA--CDC, HCFA. Final rule with comment period.
    Fed Regist; 1998 Oct; 63(198):55031-4. PubMed ID: 10185832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare, Medicaid, and CLIA programs; extension of certain effective dates for clinical laboratory requirements under CLIA. Centers for Disease Control and Prevention (CDC) and Health Care Financing Administration (HCFA), HHS. Final rule with comment period.
    Fed Regist; 2000 Dec; 65(251):82941-4. PubMed ID: 11503740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(35):8105-7. PubMed ID: 14997866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies, and laboratories that have withdrawn from the program--SAMHSA. Notice.
    Fed Regist; 1998 Feb; 63(21):5394-6. PubMed ID: 10177334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare program; list of covered surgical procedures for ambulatory surgical centers--HCFA. Proposed notice and request for comment.
    Fed Regist; 1984 Feb; 49(33):6023-5. PubMed ID: 10264556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fiscal year (FY) 1999 funding opportunities. Substance Abuse and Mental Health Services Administration, HHS. Notice of funding availability.
    Fed Regist; 1999 Mar; 64(44):11027-31. PubMed ID: 10557624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fiscal year (FY) 1999 funding opportunities. Substance Abuse and Mental Health Services Administration, HHS. Notice of funding availability.
    Fed Regist; 1999 Mar; 64(46):11935-8. PubMed ID: 10557616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.